Osteonecrosis of the jaws in intravenous bisphosphonate use: Proposal for a modification of the clinical classification

Oral Oncology

Volumn 45, Issue 7, 2009, Pages 645-646

  Bagan, Jose V ^a   Jimenez, Yolanda ^a   Diaz, Jose M ^a   Murillo, Judith ^a   Sanchis, Jose M ^a   Poveda, Rafael ^a   Carbonell, Enrique ^a   Gavalda, Carmen ^a   Scully, Crispian ^b  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE;

ANTIBIOTIC THERAPY; BONE PAIN; CLINICAL FEATURE; DISEASE CLASSIFICATION; HUMAN; JAW FRACTURE; JAW OSTEONECROSIS; LETTER; LONG TERM CARE; PRIORITY JOURNAL; SKIN FISTULA;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; HUMANS; INJECTIONS, INTRAVENOUS; JAW DISEASES; OSTEONECROSIS; PRACTICE GUIDELINES AS TOPIC;

EID: 67449105031     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.05.011     Document Type: Letter

References (8)

1. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 9 (2003) 1115-1117
2. Marx R.E., Cillo Jr. J.E., and Ulloa J.J. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65 12 (2007) 2397-2410
3. Bagan J.V., Murillo J., Jimenez Y., Poveda R., Milian M.A., Sanchis J.M., et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 34 2 (2005) 120-123
4. Bagan J.V., Jimenez Y., Murillo J., Hernandez S., Poveda R., Sanchis J.M., et al. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 42 3 (2006) 327-329
5. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 5 (2004) 527-534
6. Ruggiero S.L., Fantasia J., and Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 4 (2006) 433-441
7. Vescovi P., Manfredi M., Merigo E., and Meleti M. Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 66 4 (2008) 831-832
8. Longobardi G., Boniello R., Gasparini G., Pagano I., and Pelo S. Surgical therapy for osteonecotic lesions of the jaws in patients in therapy with bisphosphonates. J Craniofac Surg 18 5 (2007) 1012-1017